Disease | hepatitis |
Symptom | |hepatocellular carcinoma |
Sentences | 261 |
PubMedID- 20652159 | Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis b virus-related cirrhosis. |
PubMedID- 24930484 | Here, we assessed the prognostic performance of lsps in predicting the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
PubMedID- 22957763 | A high incidence of tumor recurrence and metastasis has been reported in hepatocellular carcinoma (hcc) patients with chronic hepatitis b virus (hbv) infection. |
PubMedID- 26421419 | Background: hepatectomy in hepatocellular carcinoma (hcc) patients lead to postoperative hepatitis b virus (hbv) reactivation (phr) as well as immunosuppression. |
PubMedID- 25873850 | The present case was a young man, a known case of chronic hepatitis b with multiple recurrent hepatocellular carcinoma, who presented with clinical sepsis and jaundice. |
PubMedID- 21157144 | A 57-yr-old female patient with hepatocellular carcinoma due to hepatitis c virus received a liver transplantation. |
PubMedID- 21537363 | A 78-year-old male who experienced multiple recurrences of hepatocellular carcinoma (hcc) with hepatitis c virus (hcv)-related cirrhosis underwent transcatheter arterial chemoembolization and ablation and survived for more than 10 years. |
PubMedID- 23099187 | Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study. |
PubMedID- 23044807 | Association of xrcc1, xrcc3, and xpd genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis b and c virus. |
PubMedID- 23200676 | hepatocellular carcinoma (hcc) is associated with hepatitis b virus (hbv) chronicity and dietary exposure to aflatoxin, a mutagen targeting codon 249 of tumor suppressor tp53 (r249s mutation). |
PubMedID- 23280722 | Il17a gene polymorphisms, serum il-17a and ige levels, and hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection. |